# Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations

**URL:** <https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563>\
**Category:** nCoV-2019 Genomic Epidemiology\
**Created:** [December 18, 2020, 11:24pm UTC](https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 "2020-12-18T23:24:04Z")\
**Posts on this page:** 1\
**Showing post:** 5

<div class="post-metadata">

**Author:** ![isabel](https://virological.org/letter_avatar_proxy/v4/letter/i/977dab/32.png) [@isabel](https://virological.org/u/isabel)\
**Post date:** [December 21, 2020, 1:13am UTC](https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563/5 "2020-12-21T01:13:58Z")

</div>

Sorry for too many questions … but I appreciate your work and opinion  
One more …  
Faster evolutionary rate of the vírus was reported in Mink associated SARS-CoV-2 in Netherlands by Munnink et al.  
Do you think that spillover to new host species could speed up the evolutionary rate of SARS-CoV-2?  
In HIV-1 and EIAV vaccine studies there are reports of the emergence of new variants for immune evasion. The same is associated to antivirals .  
Why with SARS-CoV-2 everyone is betting in the lack of immune evasion responses to vaccines ?  
What is the scientifc evidence that we have that are indicating that we’ll have stable and low evolutionary rates in SARS-COV-2?

---

_[View the full topic](https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563)._